Nurse Practitioner in Lake City, CO Accepting Medicare
1 Nurse Practitioner nurses found. Showing 1 - 1
 Mrs. Sherry Rae Huisman, FNP-BC Nurse Practitioner - Family Medicare: Accepting Medicare Assignments Practice Location: 700 N Henson St, Lake City, CO 81235 Phone: 970-944-2331 Fax: 970-944-2320 |
News Archive
Celgene receives Japan's MHLW approval for REVLIMID in deletion 5q myelodysplastic syndrome patients
Celgene International Sàrl announced that REVLIMID (lenalidomide) has been granted full marketing authorization by Japan's Ministry of Health, Labour and Welfare (MHLW) for the treatment of patients with myelodysplastic syndromes (MDS) associated with a deletion 5q cytogenic abnormality. REVLIMID was also approved in June 2010 in combination with dexamethasone, for the treatment of patients with relapsed or refractory multiple myeloma who have received at least one prior standard therapy.
OIST scientists model molecular basis of learning in the cerebellum
The process we call learning is in fact a well-orchestrated symphony of thousands of molecular reactions, but the exact interplay between these reactions remains largely unknown.
Sen. Graham gun bill would bar more with mental illness from buying guns
Three senators potentially facing tough re-election challenges next year introduced NRA-endorsed legislation Wednesday that would bar more people from buying guns due to mental illness.
MiMedx Group's revenue increases 108% to $40.8 million in first quarter 2015
MiMedx Group, Inc., the leading regenerative medicine company utilizing human amniotic tissue and patent-protected processes to develop and market advanced products and therapies for the Wound Care, Surgical, Orthopedic, Spine, Sports Medicine, Ophthalmic and Dental sectors of healthcare, announced today its record results for the first quarter of 2015.
UCB and sanofi-aventis U.S. receive FDA's approval for XYZAL to treat allergies in children
UCB and sanofi-aventis U.S. announced today that the U.S. Food and Drug Administration (FDA) has approved XYZAL(R) (levocetirizine dihydrochloride) for children age six months and older for the relief of symptoms of perennial allergic rhinitis (indoor allergies) and chronic idiopathic urticaria (chronic hives) and for children age two years and older for symptoms of seasonal allergic rhinitis (outdoor allergies).
› Verified 2 days ago